Men with a particular gene mutation affected most, researchers find.
Primary care screening patterns have changed as a result of the USPSTF recommendation.
Study reveals comparable rates of freedom from biochemical failure at 5 years.
This effect appears to occur mainly in men who experience recurrence when they are younger than 65 and in those with low-risk cancer.
Biopsies triggered by an abnormal DRE alone were significantly less likely to detect clinically significant prostate cancer than biopsies triggered by an abnormal PSA alone.
Gleason 9-10 tumors are associated with a greater risk of biochemical and clinical recurrence, but not overall survival.
Researchers report on a study in which survivors were followed up for a median of 14 years.
Researchers concluded that margin status is a surrogate for established risk criteria.
Neutrophil-lymphocyte ratio could have a prognostic role in localized prostate cancer.
The 10-year rates of biochemical and clinical recurrence are comparable to those of open surgery.
A PSA doubling time of less than 3 years and a Gleason score of 8-10 were associated with an increased risk of metastasis.
Recent study shows that 71% of prostate cancer patients with very-low-risk disease were placed on active surveillance.
Only 7.4% of patients receive ART after radical prostatectomy despite the presence of adverse pathologic features, study shows.
Current and former smokers are at higher risk of complications within 30 days after radical prostatectomy or cystectomy.
Combination with hormone therapy can extend life by almost a year for prostate cancer patients
Prostate cancer remained stable for an average 10 extra months in men taking statins, but more trials are needed to confirm benefits, researchers say.
Although physical fitness is widely known to prevent cardiovascular disease, its impact on prostate cancer is less clear.
28.1% of patients with metastatic prostate cancer have a synchronous second primary cancer.
Patients with higher PSA, shorter PSA doubling time more likely to have second bone scan.
Researchers found real improvements in quality of life once men got active
Clinician referral to a 12-week program ups vigorous exercise levels and improves mental health.
Prolonged androgen deprivation treatment ups risk in older men with prostate cancer, especially those with comorbidities.
Obesity is associated with greater risk of PCa among African-American men compared to non-Hispanic white men.
Enzalutamide improves health-related quality of life (HRQoL) in chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).
Increased risks of mortality restricted to aspirin use after the diagnosis of prostate cancer.
Increased likelihood of prostate cancer seen with fourth repeat biopsy, men.
The Prostate Health Index improves detection of clinically significant prostate cancer.
Median time to death was shortest in men with metastatic disease at diagnosis.
High LDL cholesterol and high blood glucose, however, did increase the risk of PSA relapse.
Research raises concern about the simultaneous use of chemotherapy and fish oil.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)